ZWS Shorts Pull Back as Earnings Arrive

Zurn Elkay Water Solutions enters its Q3 print with short sellers backing away. Bearish positioning fell 10.7% over the past week to 2.5% of the free float, reaching its lowest level in at least a year. That weekly retreat is 1.9 standard deviations below the company's typical weekly move, making the drawdown unusually sharp by its own history.

Borrow conditions reinforce the picture. Availability is running at 3,441%, meaning lenders hold far more stock than has been borrowed, one of the loosest setups in the lending market. Cost to borrow is 0.42%, down 8% on the week and 16% over the past month. There is no tension in the borrow market heading into the print.

The stock closed at $49.15, up 3.0% on the week. That compares to a median weekly gain of 2.4% across its closest peers, with AWI and SSD moving in opposite directions over the same stretch, down 8.3% and up 6.1% respectively, suggesting sector signals are mixed. Options positioning is firmly in call territory, with the put/call ratio at 0.06, well below its 20-day average of 0.07, near the lowest reading of the past year.

Analysts are constructive overall, with the Street consensus sitting above the current share price: the mean price target is $56.89, implying about 16% upside from Tuesday's close. RBC Capital trimmed its target to $54 from $58 on October 14, keeping a Sector Perform rating. Oppenheimer and Barclays have been more positive in recent months, with targets at $60 and $61 respectively. The bull case centres on the 11% organic sales growth Zurn reported in Q1, with commercial and institutional end markets both expanding, and net leverage at just 0.5x. Bears point to reliance on nonresidential construction activity and the risk of margin pressure from commodity costs across copper, brass and steel.

ORTEX forecasts a 26% probability of ZWS being added to the S&P MidCap 400, with a corresponding deletion from the S&P SmallCap 600, tied to the proposed acquisition of NorthWestern Energy by Black Hills Corporation. The estimated announcement date is December 8, with a trade date around December 14. The money involved is substantial: roughly $763 million of net buying from index trackers, equivalent to 17.5 days of normal volume. These are ORTEX forecasts, not confirmed index decisions, and the dates are estimated. In 40 past comparable additions, the median move from announcement to effective date was negative 2.5%, and only 32% of stocks moved in the direction most investors assume.

The Q3 report will test whether the company's organic growth rate has held through a softer stretch for construction activity, and whether margin progress justifies a share price now trading at a P/E of around 24.6x.